Essential Biotechnology
Get Full AccessDescription
- Essential Biotechnology has a new approach to cancer therapy. Its time to learn from the failures of the targeted molecular therapies of the past and go for the jugular. We have discovered a molecule that serves as a nexus in regulating tumor cell survival- allowing the tumor cells to survive the stresses of their environment and chemotherapies. We have developed monoclonal antibodies that target this nexus and kill cancer cells by making them sensitive to stress once again. Preclinical work has shown that this approach works, even on traditionally undruggable Ras-driven cancers. Ovarian, lung, and pancreatic cancers represent multi-billion dollar clinical problems with no adequate solutions in large part due to resistance to therapy. This is a new class of drug target with a novel mechanism of action that works in concert with existing drugs. We are seeking industry partners with compatible pipelines to help us bring these new antibodies into the clinic.
-
Headquarters: , Big Bend, Wisconsin, United States
More -
Phone Number:
-
Website: https://www.essentialbiotech.com
-
Employees:2
-
Revenue:$1 - 10M
-
Legal Name:Essential Biotechnology
-
Essential Biotechnology's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Essential Biotechnology
-
What is Essential Biotechnology's official website?
Essential Biotechnology's official website is https://www.essentialbiotech.com
-
What is Essential Biotechnology's Revenue?
Essential Biotechnology's revenue is $1 - 10M
-
What is Essential Biotechnology's NAICS code?
Essential Biotechnology's NAICS code is 541713
-
How many employees are working in Essential Biotechnology
Essential Biotechnology has 2 employees
-
What is Essential Biotechnology's Industry?
Essential Biotechnology is in the industry of Biotechnology
-
Who is Essential Biotechnology's President And Chief Scientific Officer?
Essential Biotechnology's President And Chief Scientific Officer is Michael James

